Visiongain Publishes Healthcare Distribution Market Report 2021-2031

29 October 2020
Pharma

Visiongain has published a new report on Healthcare Distribution Market Report : Forecasts by Type (Pharmaceutical (Brand-name, Generic, OTC, Vitamins), Medical Device (Biopharmaceutical (Vaccines, Monoclonal Antibodies)), End User (Retail Pharmacies, Hospital Pharmacies). PLUS Profiles of Leading Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Global Healthcare Distribution Market was valued at US$ xx billion in 2020 and is projected to reach at a market value of US$ xx billion by 2031.

The healthcare distribution market is classified into different sector- Pharmaceuticals product distribution services, medical device distribution services and biopharmaceutical product distribution services.

The largest sector is pharmaceutical product distribution services because in the increase in production of pharmaceutical formulations, outsourcing of pharmaceutical manufacturing and introduction of new manufacturing techniques.

COVID-19 Impact on Healthcare Distribution Market
In this situation of COVID19 this market is only one market which is growing tremendously. Because the threat of this pandemic the world is expecting the better medicines and the most need is covid 19 vaccines. This market is growing in such a way that the players of other sectors are trying to establish in this market.

Market Drivers
The high incidence and large economic crises of chronic disease are primarily driving the market growth, high investments in R&D activities and increasing launch of new rugs and medicines in the healthcare market is supporting the growth of the distribution market.

The technological advancements along with the subsequent growth in track and trace solution in the healthcare distribution industry are further contributing to the growth of the market.

Market Opportunities
The market is gaining pace due to increase in usage of generics in the healthcare sector. Moreover the growing medical device industry is further boosting the demand in the market

The growing biosimilar markets in emerging economics is likely to create potential demands over the period.

Competitive Landscape
The expanding pharmaceutical industry along with the implementation of stringent regulations to enhance the quality and reliability of pharmaceuticals drugs are developing in the emerging economies of the region including all the countries. Some big players in the Healthcare Distribution market are-Mckesson Corporation(US).Amerisource Bergen Corporation(US),Cardinal Health Inc.(US), Owens &Minor, Inc. (US),Morris and Dickson CO. LLC (US), KeySource Medical INC (US),Rochester Drug Cooperative INC(US), Henry Schein Inc.(US),Smith Drug Company (US),FFF Enterprise (US),Patterson Companies Inc (US),Mutual Drug (US)Shanghai Pharmaceuticals Group CO LTD (China),Medline Industries (US),PHOENIX group (Germany), CuraScript SD(US).

Recent Developments
• In April 2019, Cardinal Health partnered with PANTHERx Specialty Pharmacy (US) to fortify its cell and gene therapy product range with a coordinated collection of specialty distribution, third-party logistics (3PL) services, and specialty pharmacy dispensing services.
• In April 2019, McKesson joined hands with Google Cloud (US) to improve new restructured applications and solutions for product manufacturing, specialty pharmaceutical distribution, and retail operations for pharmacies.
• In January 2018, AmerisourceBergen (US) acquired H. D. Smith (US) to augment and expand AmerisourceBergen’s considered scale and strengthen the company’s support to community pharmacies

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

Read

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

Read

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

Read

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever